Xiaoling Li

11.1k citations
222 papers · 7.9k · 4 hit papers · h-index 47

Impact in

Papers in

Xiaoling Li

216 papers receiving 7.7k citations

Xiaoling Li's Hit Papers

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant 2024 · 119 citations
1190+2+4Years since publication100200300400500

Peers

Xiaoling Li
Comparison fields: 5 of 136
  • Cancer Research 768
  • Otorhinolaryngology 307
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 1.3k
  • Immunology 743
Replace Jiang Li with:
Jiang Li China
Xin Li China
Alfredo Budillon Italy
Shrikant Anant United States
Marc Bracke Belgium
Hirohisa Yano Japan
Alessandro Sgambato Italy
Bin Li China
Min‐Liang Kuo Taiwan
Georg Feldmann Germany
Xiaoling Li relative to Jiang Li China Jiang Li's profile →
Citations per field
00.5×2×2.8×
Jiang Li · 1×
Citations per year

Countries citing papers authored by Xiaoling Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).

Fields of papers citing papers by Xiaoling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoling Li Line = papers co-authored together Xiaoling Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The role of microenvironment in tumor angiogenesis
Hit paper breakdown →
2020587
2
Neoantigen vaccine: an emerging tumor immunotherapy
Hit paper breakdown →
2019585
3 2017314
4
Single‐cell RNA sequencing in cancer research
Hit paper breakdown →
2021283
5 2019209
6 2021178
7 2018152
8 2022138
9 2006134
10 2017123
11 2020120
12
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
Hit paper breakdown →
2024119
13 2022116
14 2021111
15 2008108
16 2021108
17 2022103
18 2017102
19 2020100
20 200897

About Xiaoling Li

Xiaoling Li is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Molecular Biology, Immunology and Oncology, having authored 222 papers that have together received 7.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Head and Neck Cancer Studies (15 papers), Ferroptosis and cancer prognosis (11 papers), Cancer Immunotherapy and Biomarkers (8 papers), Nitric Oxide and Endothelin Effects (8 papers), Prostate Cancer Treatment and Research (7 papers), Advanced Drug Delivery Systems (7 papers) and interferon and immune responses (6 papers). The work is most often cited by research in Cancer Research (768 citations), Otorhinolaryngology (307 citations), Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Immunology (743 citations). Xiaoling Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Yong Li, Yongzhen Mo, Lianxiang Luo, Can Jie Guo, Fang Xiong, Qianjin Liao and Xiayu Li. Their work appears in journals such as Molecular Cancer, Journal of Biological Chemistry, Cancer Letters, Journal of Cancer and Journal of Experimental & Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact